cardiovascular disease

Racial Disparities and Social Determinants in Cardiovascular Risk Among Women with Polyendocrine Metabolic Ovarian Syndrome

By MedXY 10/24/2026

This study reveals significant racial differences in atherosclerotic cardiovascular disease risk among women with PMOS, highlighting that social determinants of health influence these disparities, particularly among Black women.

Cardiology news OB/GYN & Women's Health

Postpartum Blood Pressure Monitoring After Hypertensive Disorders of Pregnancy Predicts Long-Term Cardiovascular Risk

By MedXY 10/21/2026

This cohort study links postpartum blood pressure at 6 weeks following hypertensive pregnancy disorders with a doubled risk of future cardiovascular disease, highlighting a crucial preventive care window.

Cardiology news Public Health

Optimizing Step Counts and Intensity to Reduce Mortality Risk: Insights from UK Biobank Accelerometer Data

By MedXY 10/17/2026

This study reveals that various combinations of daily step counts and stepping intensity independently reduce all-cause and cardiovascular mortality, highlighting the importance of personalized physical activity strategies.

Cardiology news

Reducing Heat-Related Harm in People with Heart Disease: Key Recommendations from the 2026 European Heart Journal Consensus

By MedXY 10/13/2026

An expert consensus provides practical, evidence-informed guidance for clinicians to protect people with cardiovascular disease from rising heat extremes, focusing on prevention, medication review, cooling strategies, and health-system preparedness.

Cardiology news

Adults with Congenital Heart Disease: Unveiling the Impact of Acquired Cardiovascular Risk Factors on Long-Term Survival

By MedXY 10/10/2026

A large cohort study highlights how acquired cardiovascular risk factors significantly influence late mortality in adults with congenital heart disease, underscoring the need for integrated care strategies.

Cardiology news Respiratory

Occupational Dust and Fume Exposure Elevates Risk of Respiratory and Cardiovascular Complications in Smokers

By MedXY 10/09/2026

Occupational exposure to both dust and fumes significantly increases the risk of future respiratory exacerbations, atherosclerotic cardiovascular disease, and pneumonia in smokers and former smokers, underscoring the need for targeted preventive strategies.

Cardiology Diabetes & Endocrinology news

Functional Hypothalamic Amenorrhea Phenotype and Cardiovascular Disease Risk

By MedXY 10/07/2026

Functional hypothalamic amenorrhea (FHA) in mid-adulthood is linked to increased coronary heart disease risk and type 2 diabetes, independent of traditional factors, highlighting menstrual irregularities as early cardiometabolic risk indicators.

Cardiology Clinical Updates news

Cardiovascular-Kidney-Metabolic Multimorbidity in Heart Failure: Prevalence, Prognostic Impact, and Clinical Implications Across Ejection Fraction Phenotypes

By MedXY 10/05/2026

Most heart failure patients harbor multiple cardiovascular-kidney-metabolic conditions, which independently escalate mortality and readmission risk, especially in HFrEF, underscoring the need for integrated management strategies tailored by ejection fraction.

Cardiology Diabetes & Endocrinology news

Unraveling the Predictors of Peak Weight Loss with Semaglutide in Cardiovascular Patients: Insights from the SELECT Trial

By MedXY 09/29/2026

In the SELECT trial, baseline clinical factors poorly predicted peak body weight loss with semaglutide, highlighting the role of sex and dosage but underscoring substantial unexplained variability in patient response.

Cardiology Internal Medicine news

Multidimensional Functional Decline Precedes Cardiovascular Events: Insights from the ASPREE Study

By MedXY 09/28/2026

Declines in frailty, intrinsic capacity, and physical quality of life occur years before cardiovascular events, highlighting a prolonged window for early intervention in older adults.

Clinical Updates Diabetes & Endocrinology news

Impact of Age at Type 1 Diabetes Onset on Mortality and Organ Complications: Insights from a Nationwide Swedish Cohort

By MedXY 09/23/2026

Younger age at type 1 diabetes diagnosis significantly increases risks of mortality, cardiovascular, and kidney complications; each additional year delay in onset reduces these risks. This review synthesizes nationwide cohort findings and contextualizes them within existing literature on disease progression and outcomes.

Clinical Updates Diabetes & Endocrinology news

Efficacy and Safety of Semaglutide According to Frailty Status: Insights from the SELECT Randomized Clinical Trial Post Hoc Analysis

By MedXY 09/21/2026

Semaglutide demonstrates consistent cardiovascular benefits and safety across frailty levels in overweight adults with cardiovascular disease, enhancing quality of life and frailty status without increased adverse events.

Cardiology Gastroenterology news

Subclinical Liver Disease as a Silent Driver of Cardiovascular Risk: Insights from a Large-Scale Prospective Study

By MedXY 09/15/2026

Subclinical liver disease, marked by steatosis, fibrosis, and functional impairment, independently and synergistically increases cardiovascular disease risk. Incorporating non-invasive liver biomarkers could enhance CVD risk prediction and inform prevention strategies.

Cardiology news Public Health

Unveiling the Cardiovascular Toll of Long-Term Wildfire Smoke PM2.5 Exposure in Older Americans

By MedXY 09/15/2026

Long-term cumulative exposure to wildfire smoke PM2.5 significantly increases cardiovascular hospitalizations among U.S. older adults, with notable risks in ischemic heart disease and arrhythmias, highlighting the need for targeted public health measures.

Cardiology Hematology-Oncology news

Designing Cardiovascular Outcomes Trials in Clonal Hematopoiesis: A Precision Medicine Imperative

By MedXY 09/14/2026

Clonal hematopoiesis of indeterminate potential (CHIP) poses a novel cardiovascular risk. This article explores challenges and strategies for designing cardiovascular outcomes trials tailored to CHIP’s genetic heterogeneity and clinical complexity.

Cardiology news Oncology

Rising Cardiovascular Disease Burden at Cancer Diagnosis: Insights from a National English Cohort and Future Projections

By MedXY 09/02/2026

This national English study reveals a significant increase in pre-existing cardiovascular disease among patients at cancer diagnosis over two decades, projecting nearly half will have cardiovascular comorbidities by 2050, underlining urgent cardio-oncology integration needs.

Cardiology news Public Health

Sustained Cardiovascular Benefits of Intensive Blood Pressure Management Led by Nonphysician Providers: 7-Year Follow-Up of the CRHCP Trial

By MedXY 08/30/2026

Long-term intensive BP control led by trained nonphysician community providers significantly lowers cardiovascular risk over 7 years, with benefits persisting 3 years post-intervention in rural China.

Cardiology Diabetes & Endocrinology news

Semaglutide’s Impact on Inflammation and Cardiovascular Risk in Overweight Patients: Insights from the SELECT Trial

By MedXY 08/21/2026

In the SELECT trial, semaglutide significantly lowered hsCRP levels and major cardiovascular events in patients with established atherosclerotic cardiovascular disease and overweight or obesity, suggesting inflammation reduction as a possible mechanism behind cardiovascular benefits.

Allergy & Immunology Cardiology news

Unveiling Hidden Immune Signatures in Cardiovascular Disease Through Single-Cell Multi-Omics

By MedXY 08/21/2026

Single-cell multi-omics profiling reveals novel immune signatures linked to coronary artery disease and cardiovascular outcomes, independent of traditional inflammatory markers, offering new avenues for risk stratification and personalized therapy.

Cardiology Internal Medicine news

Longitudinal Heart Stress Changes and Cardiovascular Risk in Older Adults: Insights from NT-proBNP Dynamics

By MedXY 08/20/2026

Changes in NT-proBNP levels over three years define heart stress status, which improves cardiovascular and mortality risk prediction in older adults without prior CVD, underscoring its utility in clinical risk stratification.